Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

U.S. FDA accepts biologics license application for Mylan and Biocon’s proposed biosimilar pegfilgras

pharmaasiaMarch 06, 2017

Tag: Mylan , biosimilar

PharmaSources Customer Service